Specialty Pharmacy

Top news of the week from Specialty Pharmacy Times.

Spending for adalimumab has tripled from 2012 from $4.5 billion.

Pharmacists who are unfamiliar with either the principles of infectious disease or HIV may miss errors.

Mass spectrometry device rapidly identifies molecular profile of cancerous tissue.

Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.

A look into the differences between specialty pharmacies in integrated delivery networks and academic medical centers.

Payers and manufacturers look for specialty pharmacy partners with several key aspects.

Consistency among caregivers can be an important factor for patients undergoing treatment for cancer.

Several drugs are in the pipeline for the treatment of specialty conditions, including cancer and multiple sclerosis.

Reducing the cost of antiretroviral therapy could produce even more savings in the treatment of HIV.

Top news of the day from across the health care landscape.

Two different Copaxone injection doses approved for relapsing forms of multiple sclerosis.

Patients with chronic kidney disease are at risk for several comorbid conditions, including cardiovascular disease.

Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.

The fate of the 340B program is unclear amid several proposals to make changes.

The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.

Ramping up programs for injection drug users is a key part in preventing transmission of hepatitis C.

Top news of the day from across the health care landscape.

The neurodegenerative phase of multiple sclerosis remains a significant challenge for researchers.

Women in Specialty Pharmacy Lunch brings together leaders from various aspects of the specialty landscape.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Payer requirements for outcomes data are becoming more stringent.

Testing and treatment programs should focus on populations driving new cases of hepatitis C virus.

Outcomes and accreditation measures are among the key factors in building a successful specialty pharmacy, according to a session at the annual NASP meeting.

Becoming an accredited specialty pharmacy requires a large time investment and a significant commitment to properly record and report specific data.

Nearly 80% of Americans said they would follow their pharmacist on social media.

Top news of the day from across the health care landscape.

Gadolinium-containing imaging agent could improve breast cancer survival.